The pharmaceutical company’s diabetes drug business may play a role, according to Sydbank senior analyst Søren Løntoft Hansen.
发布者:BY CHRISTOPHER DUE KARLSSON,转转请注明出处:https://robotalks.cn/analyst-points-to-several-reasons-for-novos-silence-over-next-steps-for-weight-loss-tablet-2/